Succinate Dehydrogenase-deficient Renal Cell Carcinoma

• CLINICAL_TRIALS research · 2026-01-28
  Clinical Trial Update: An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or Biopsy [NA]

  This is an update on a clinical research study (NCT04623502) investigating kidney and urothelial tumor metabolism in patients undergoing sur…

• CLINICAL_TRIALS trial_result · 2025-09-22
  Clinical Trial Update: A Study of Nivolumab In Combination With Cabozantinib in Patients With Non-Clear Cell Renal Cell Carcinoma [Phase 2]

  Phase 2 study of nivolumab in combination with cabozantinib in patients with non-clear cell renal cell carcinoma; the trial is currently act…

• CLINICAL_TRIALS trial_result · 2024-12-27
  Clinical Trial Update: Talazoparib and Avelumab in Participants With Metastatic Renal Cell Carcinoma [Phase 2]

  A Phase 2 clinical trial evaluating talazoparib plus avelumab in metastatic renal cell carcinoma, including fumarate hydratase–deficient and…